Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Cendrowicz E, Jacob L, Greenwald S, Tamir A, Pecker I, Tabakman R, Ghantous L, Tamir L, Kahn R, Avichzer J, Aronin A, Amsili S, Zorde-Khvalevsky E, Gozlan Y, Vlaming M, Huls G, van Meerten T, Dranitzki ME, Foley-Comer A, Pereg Y, Peled A, Chajut A, Bremer E. Cendrowicz E, et al. Among authors: chajut a. J Exp Clin Cancer Res. 2022 Mar 14;41(1):97. doi: 10.1186/s13046-022-02256-x. J Exp Clin Cancer Res. 2022. PMID: 35287686 Free PMC article.
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.
Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H, Meiri E, Chajut A, Rosenwald S, Aharonov R, Spector Y. Pentheroudakis G, et al. Among authors: chajut a. Mol Cancer. 2013 Jun 10;12:57. doi: 10.1186/1476-4598-12-57. Mol Cancer. 2013. PMID: 23758919 Free PMC article.
A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M, Huszar M, Fogt F, Ashkenazi K, Sanden M, Goren E, Dromi N, Zion O, Burnstein I, Chajut A, Spector Y, Aharonov R. Meiri E, et al. Among authors: chajut a. Oncologist. 2012;17(6):801-12. doi: 10.1634/theoncologist.2011-0466. Epub 2012 May 22. Oncologist. 2012. PMID: 22618571 Free PMC article.
MicroRNAs as a potential prognostic factor in gastric cancer.
Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. Brenner B, et al. Among authors: chajut a. World J Gastroenterol. 2011 Sep 21;17(35):3976-85. doi: 10.3748/wjg.v17.i35.3976. World J Gastroenterol. 2011. PMID: 22046085 Free PMC article.
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Varadhachary GR, et al. Among authors: chajut a. Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531815
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.
Elyakim E, Sitbon E, Faerman A, Tabak S, Montia E, Belanis L, Dov A, Marcusson EG, Bennett CF, Chajut A, Cohen D, Yerushalmi N. Elyakim E, et al. Among authors: chajut a. Cancer Res. 2010 Oct 15;70(20):8077-87. doi: 10.1158/0008-5472.CAN-10-1313. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20924108
28 results